Drug firms unveil price cuts

Aid agencies welcome move to make life-saving drugs cheaper in the developing world, with caveats.

    A number of leading drug firms have announced plans to cut prices dramatically for life-saving drugs in the developing world.

    UK-based Glaxo Smithkline, says it will reduce the cost of its Rotarix vaccine by 67 per cent. It will now cost $5 to immunise a child against rotavirus, a leading cause of diarrhoea.

    The price cuts have been broadly welcomed by aid agencies. But Save the Children says it only goes partly in plugging a $3.7bn shortfall needed to produce life-saving drugs.

    Al Jazeera spoke to Paul Cook, the head of advocacy at Tearfund.

    SOURCE: Al Jazeera


    YOU MIGHT ALSO LIKE

    'We scoured for days without sleeping, just clothes on our backs'

    'We scoured for days without sleeping, just clothes on our backs'

    The Philippines’ Typhoon Haiyan was the strongest storm ever to make landfall. Five years on, we revisit this story.

    How Moscow lost Riyadh in 1938

    How Moscow lost Riyadh in 1938

    Russian-Saudi relations could be very different today, if Stalin hadn't killed the Soviet ambassador to Saudi Arabia.

    Daughters of al-Shabab

    Daughters of al-Shabab

    What draws Kenyan women to join al-Shabab and what challenges are they facing when they return to their communities?